We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boxed Warning Added to Plavix Highlights Metabolism Issues
Boxed Warning Added to Plavix Highlights Metabolism Issues
March 19, 2010
Sanofi-Aventis and Bristol-Myers Squibb’s blockbuster anti-clotting drug Plavix will now carry a boxed warning about the drug’s ineffectiveness in some patients with a genetic mutation.